-
Commonly used heart drug may up cardiac arrest risk
expressbpd
March 19, 2019
Sudden cardiac arrest is lethal in minutes if untreated
-
No association between antiepileptic drug use and dementia
europeanpharmaceuticalreview
February 19, 2019
Antiepileptic drugs have been found to have no association with dementia, with researchers looking at the data of over 50,000 patients…
-
Drug costs soaring? Express Scripts says 2018 growth was lowest in 25 years
fiercepharma
February 11, 2019
Politicians have been hitting hard at pharma for months and years, using terms such as “skyrocketing,” “astronomical” or “soaring” to describe drug costs.
-
Proposed Medicare reforms spark comments about drugs
europeanpharmaceuticalreview
January 31, 2019
The Centers for Medicare and Medicaid Services, part of the Department of Health and Human Services has proposed a reform titled “Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses.”
-
Test run of drug prices in ads exposes a loophole—and pharma's already using it
fiercepharma
January 31, 2019
It’s no surprise that listing the high price of a drug in advertising would discourage consumers.
-
Manufacturer to pay penalty for entire batch if single drug found substandard: Govt
expressbpd
January 28, 2019
According to a government official, the new provision, proposed by the Central Drugs Standard Control Organisation (CDSCO) for addition in the existing Drug and Cosmetics Act, will apply even if the packaging is faulty
-
FDA delays review of peanut allergy drug amid Trump shutdown
pharmaphorum
January 17, 2019
One of the first pharma victims of the current partial shutdown of the US government has emerged after the FDA said it would delay a review of a peanut allergy drug from Aimmune Therapeutics.
-
Lilly pays AC Immune $81M upfront for preclinical Alzheimer’s drug
fiercebiotech
December 27, 2018
Eli Lilly has paid CHF 80 million ($81 million) upfront for the worldwide rights to AC Immune’s tau aggregation inhibitors in Alzheimer’s disease.....
-
Roivant strikes broad pipeline pact with Daiichi
fiercebiotech
December 25, 2018
Roivant has secured an option to license a stream of drugs from Daiichi Sankyo. The deal is the first time Roivant has formed a framework to facilitate the ongoing in-licensing of drugs from a company rather than picked up assets on an ad hoc basis.....
-
Health Canada warning: Health products by Botanicals Inc. may be harmful
biospectrumasia
December 17, 2018
Health Canada has seized all of the products, prescription drug ingredients and manufacturing equipment found at the site, and suspended the 11 natural health product licences held by the company